IRIDEX Corporation Stock Analysis & AI Score
IRIDEX Corporation (IRIX) has an ST Score of 50.2 (C+), driven by its Forecast (A) and held back by its Momentum (D). Analysts rate it Buy with a $2.75 price target (+336.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
IRIDEX Corporation (IRIX) has an ST Score of 50.2 (C+), driven by its Forecast (A) and held back by its Momentum (D). Analysts rate it Buy with a $2.75 price target (+336.5% upside).
- Strongest
- ForecastA
- Weakest
- MomentumD
All factor grades
- ForecastA
- ValuationA-
- GrowthB
- ProfitabilityC+
- Financial StrengthC-
- MomentumD
- Piotroski3/9
Contact
IRIX stock: frequently asked questions
What is IRIX's ST Score?
IRIDEX Corporation (IRIX) has an ST Score of 50.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IRIX a buy, hold, or sell?
Analysts rate IRIX a Buy, with a price target of $2.75 (+336.5% vs the current price). Our ST Score grades it C+ (50.2/100). The ST Score is a data-driven signal, not a recommendation.
What are IRIX's factor grades?
Valuation A-, Profitability C+, Financial Strength C-, Momentum D, Growth B, Forecast A.
What is IRIX's valuation grade?
IRIDEX Corporation (IRIX) earns a valuation grade of A-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IRIX's growth grade?
IRIDEX Corporation (IRIX) earns a growth grade of B, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IRIX's profitability grade?
IRIDEX Corporation (IRIX) earns a profitability grade of C+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IRIX's financial strength grade?
IRIDEX Corporation (IRIX) earns a financial strength grade of C-, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IRIX?
The average analyst price target for IRIDEX Corporation (IRIX) is $2.75 from 4 analysts, which is +336.5% versus the recent price of $0.63.
What is IRIX's Piotroski score?
IRIDEX Corporation (IRIX) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.